We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Proton Treatment Center Established in Saudi Arabia

By HospiMedica International staff writers
Posted on 15 Feb 2012
A new proton treatment facility is being equipped to provide cutting-edge cancer treatment in Riyadh (Saudi Arabia).

Varian Medical Systems (Palo Alto, CA, USA) has booked a USD 77 million order with Saudi Particle Therapy Centre, LLC to equip a new proton therapy facility at the King Fahd Medical Center (Riyadh, Saudi Arabia). More...
Varian will equip the new center with a ProBeam system for five treatment rooms as well as two TrueBeam medical linear accelerators. Equipment delivery and installation is expected to begin in spring 2013 and patient treatments are scheduled to start in late 2014. The agreement will also include a multiyear service contract that should commence as the installation is completed.

“We are honored to have been selected to supply our equipment and software for this prestigious new facility, which will make life-saving proton therapy treatments available for the first time to cancer patients in this region,” said Tim Guertin, Varian’s chief executive officer. “This is an exciting step forward for our Varian Particle Therapy business.”

Proton therapy makes it possible to treat specific types of cancer more precisely and with potentially fewer side effects than with conventional radiation therapy. With proton therapy, the risk of damage to healthy tissues is reduced. The technology can be applied for many of the most common types of cancer and offers advantages when treating tumors close to radiosensitive tissues. In pediatric patients, the risk of developing a new, radiation-induced cancer later in life can be reduced.

“We believe that more and more proton centers will want to employ the full suite of Varian products and technology for radiotherapy and radiosurgery as well as particle therapy for world-class cancer treatments,” said Mr. Guertin. “The combination of these technologies based on 60 years of innovation puts Varian in a unique position to help advance clinical care for patients around the world.”

Varian is currently installing and commissioning its ProBeam system at the Scripps Proton Center near San Diego (CA, USA). The company has also been selected to provide equipment for new proton therapy centers at the University of Maryland (College Park, USA) and in Mestre (Italy). It has been recognized as the preferred provider for a new center at Emory University (Atlanta, GA, USA).

Related Links:

Varian Medical Systems




Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Pediatric Mask
Respire SOFT
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.